{"name":"JAZZ PHARMS","slug":"jazz-pharms","ticker":"","exchange":"","domain":"jazzpharms.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharmaceuticals","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":1000000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[{"name":"Epidiolex","genericName":"CANNABIDIOL","slug":"cannabidiol","revenue":800000000,"yoyGrowth":0,"percentOfTotal":80},{"name":"Defitelio","genericName":"DEFIBROTIDE","slug":"defibrotide","revenue":200000000,"yoyGrowth":0,"percentOfTotal":20}],"timeline":[{"date":"2011-01-01","label":"Erwinase first approved","drug":"Erwinase","drugSlug":"crisantaspase","type":"approval","sentiment":"positive"},{"date":"2016-01-01","label":"Defitelio first approved","drug":"Defitelio","drugSlug":"defibrotide","type":"approval","sentiment":"positive"},{"date":"2018-01-01","label":"Epidiolex first approved","drug":"Epidiolex","drugSlug":"cannabidiol","type":"approval","sentiment":"positive"},{"date":"2024-01-01","label":"Ziihera first approved","drug":"Ziihera","drugSlug":"zanidatamab","type":"approval","sentiment":"positive"},{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":800000000,"percentOfTotal":80,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Epidiolex","genericName":"CANNABIDIOL","slug":"cannabidiol","indication":"Lennox-Gastaut syndrome","status":"marketed","revenue":800000000}]},{"name":"Other","slug":"other","revenue":200000000,"percentOfTotal":20,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Defitelio","genericName":"DEFIBROTIDE","slug":"defibrotide","indication":"Veno-occlusive disease of the liver","status":"marketed","revenue":200000000}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"cardiovascular","drugs":[{"name":"Erwinase","genericName":"CRISANTASPASE","slug":"crisantaspase","indication":"Acute lymphoid leukemia","status":"marketed"},{"name":"Ziihera","genericName":"ZANIDATAMAB","slug":"zanidatamab","indication":"biliary tract cancer (BTC)","status":"marketed"}]}],"pipeline":[{"name":"Epidiolex","genericName":"CANNABIDIOL","slug":"cannabidiol","phase":"marketed","mechanism":"Epidiolex works by inhibiting the activity of caspase-1, a protein involved in the inflammatory response and neuronal excitability.","indications":["Lennox-Gastaut syndrome","Severe myoclonic epilepsy in infancy"],"catalyst":""},{"name":"Defitelio","genericName":"DEFIBROTIDE","slug":"defibrotide","phase":"marketed","mechanism":"Defitelio works by inhibiting platelet aggregation and improving blood flow through the small blood vessels in the liver.","indications":["Veno-occlusive disease of the liver"],"catalyst":""},{"name":"Erwinase","genericName":"CRISANTASPASE","slug":"crisantaspase","phase":"marketed","mechanism":"Enzyme","indications":["Acute lymphoid leukemia"],"catalyst":""},{"name":"Ziihera","genericName":"ZANIDATAMAB","slug":"zanidatamab","phase":"marketed","mechanism":"Zanidatamab works by binding to two different parts of the HER2 protein, blocking its growth-promoting signals and slowing tumor growth.","indications":["biliary tract cancer (BTC)","biliary tract cancer (BTC)"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":4},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}